These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29274331)

  • 1. Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
    Höllriegl W; Bauer A; Baumgartner B; Dietrich B; Douillard P; Kerschbaumer RJ; Höbarth G; McKee JS; Schinagl A; Tam FWK; Thiele M; Weber A; Wolfsegger M; Turecek M; Muchitsch EM; Scheiflinger F; Glantschnig H
    Eur J Pharmacol; 2018 Feb; 820():206-216. PubMed ID: 29274331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.
    Thiele M; Kerschbaumer RJ; Tam FW; Völkel D; Douillard P; Schinagl A; Kühnel H; Smith J; McDaid JP; Bhangal G; Yu MC; Pusey CD; Cook HT; Kovarik J; Magelky E; Bhan A; Rieger M; Mudde GC; Ehrlich H; Jilma B; Tilg H; Moschen A; Terhorst C; Scheiflinger F
    J Immunol; 2015 Sep; 195(5):2343-52. PubMed ID: 26209628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
    Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
    J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat.
    Miyazaki K; Isbel NM; Lan HY; Hattori M; Ito K; Bacher M; Bucala R; Atkins RC; Nikolic-Paterson DJ
    Clin Exp Immunol; 1997 May; 108(2):318-23. PubMed ID: 9158105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
    Yang N; Nikolic-Paterson DJ; Ng YY; Mu W; Metz C; Bacher M; Meinhardt A; Bucala R; Atkins RC; Lan HY
    Mol Med; 1998 Jun; 4(6):413-24. PubMed ID: 10780884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
    Lan HY; Mu W; Yang N; Meinhardt A; Nikolic-Paterson DJ; Ng YY; Bacher M; Atkins RC; Bucala R
    Am J Pathol; 1996 Oct; 149(4):1119-27. PubMed ID: 8863661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of macrophage migration inhibitory factor in human glomerulonephritis.
    Lan HY; Yang N; Nikolic-Paterson DJ; Yu XQ; Mu W; Isbel NM; Metz CN; Bucala R; Atkins RC
    Kidney Int; 2000 Feb; 57(2):499-509. PubMed ID: 10652026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.
    Thiele M; Donnelly SC; Mitchell RA
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis.
    Ferhat M; Mangano K; Mirkina I; Mayer J; Rossmueller G; Schinagl A; Kerschbaumer R; Nicoletti F; Thiele M; Landlinger C
    Eur J Pharmacol; 2023 Oct; 956():175997. PubMed ID: 37579967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.
    Schinagl A; Kerschbaumer RJ; Sabarth N; Douillard P; Scholz P; Voelkel D; Hollerweger JC; Goettig P; Brandstetter H; Scheiflinger F; Thiele M
    Biochemistry; 2018 Mar; 57(9):1523-1532. PubMed ID: 29412660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
    Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
    Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppressive effects of GTW treatment on infiltration of inflammatory cell in glomeruli in anti-Thy1.1 glomerulonephritis].
    Wan Y; Sun W; Che X; Yang H; Ge M; Dai W; Shimizu F
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):72-7. PubMed ID: 19382456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
    Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E
    Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo.
    Hussain F; Freissmuth M; Völkel D; Thiele M; Douillard P; Antoine G; Thurner P; Ehrlich H; Schwarz HP; Scheiflinger F; Kerschbaumer RJ
    Mol Cancer Ther; 2013 Jul; 12(7):1223-34. PubMed ID: 23619302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
    Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD
    J Immunol; 1999 May; 162(9):5519-27. PubMed ID: 10228033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIF in kidney diseases : A story of Dr. Jekyll and Mr. Hyde.
    Boor P
    Pathologe; 2019 Jun; 40(Suppl 1):25-30. PubMed ID: 30569239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis.
    Boyce NW; Tipping PG; Holdsworth SR
    Kidney Int; 1986 Nov; 30(5):673-7. PubMed ID: 3537459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
    Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic.
    Rossmueller G; Mirkina I; Maurer B; Hoeld V; Mayer J; Thiele M; Kerschbaumer RJ; Schinagl A
    Mol Cancer Ther; 2023 May; 22(5):555-569. PubMed ID: 37067909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.